B7-33 6mg
CAS: N/A
B7-33 6mg from BioPeptides is a high-purity synthetic relaxin-derived research peptide engineered for advanced in-vitro receptor signaling investigations. Produced using Solid-Phase Peptide Synthesis (SPPS) and validated through HPLC, Mass Spectrometry, and UV spectrophotometry, each batch ensures ≥99% purity, structural precision, and reproducible laboratory performance across European research institutions.
$310.00
Research Use Only
Advanced Research Peptide Overview
B7-33 is a synthetic relaxin-derived research peptide supplied as a high-purity lyophilized powder for laboratory investigation.
It is widely studied in controlled in-vitro environments for its selective interaction with relaxin family peptide receptors.
Although no CAS number is currently assigned, B7-33 is fully characterized through analytical validation to meet European research documentation and reproducibility standards.
Scientific Background and Research Importance
Synthetic peptides derived from endogenous signaling proteins are essential tools in modern molecular and cellular biology research.
B7-33 is investigated for its selective receptor-mediated signaling behavior under controlled laboratory conditions.
Researchers utilize this peptide to examine downstream cellular communication pathways, structure–function relationships, and regulated gene expression models.
Its predictable biochemical behavior supports consistent and reproducible experimental workflows in regulated European research environments.
Mechanism of Action in Research Models
- Selective modulation of relaxin family peptide receptor signaling pathways
- Influence on regulated intracellular communication cascades
- Support of structure–function relationship investigations
- Facilitation of controlled peptide–receptor binding studies
- Modulation of downstream signaling pathway analysis in vitro
Primary Research Applications
Peptide–Receptor Interaction Studies: Analyzing receptor selectivity, ligand binding affinity, and downstream signaling mechanisms in controlled laboratory models.
Selective Relaxin Receptor Signaling Research: Investigating pathway-specific receptor activation and intracellular response dynamics.
Cellular Communication Analysis: Exploring regulated signaling cascades and biochemical pathway modulation.
Structure–Function Research: Evaluating molecular stability, structural behavior, and receptor-binding specificity.
Regenerative and Metabolic Models: Supporting controlled in-vitro studies involving energy regulation and cellular response mechanisms.
Molecular Characteristics
- Molecular Type: Synthetic relaxin-derived research peptide
- Structure: Linear peptide chain
- CAS Identifier: Not Assigned (N/A)
- Form: Lyophilized powder
- Stability: High when stored under recommended laboratory conditions
Stability Profile and Storage Recommendations
- Supplied as a lyophilized powder for enhanced long-term stability
- Recommended storage at −20°C
- Protect from moisture and prolonged light exposure
- Avoid repeated freeze–thaw cycles
- Reconstituted solutions remain stable for approximately 24–48 hours under refrigeration
Solubility and Reconstitution Options
- Bacteriostatic water
- Sterile saline solutions
- Buffered aqueous solutions
- Acidic buffer systems
- Compatible analytical-grade organic solvents
Technical Specifications
product Name
B7-33 6mg
cas
Not Assigned (N/A)
purity
≥99% (HPLC verified)
unit Size
6 mg
form
Lyophilized powder
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry, UV Spectrophotometry
molecular Structure
Linear synthetic peptide
stability
High when stored appropriately
Analytical Validation and Quality Assurance
- High-Performance Liquid Chromatography (HPLC) purity confirmation
- Mass Spectrometry (MS) molecular identity verification
- UV spectrophotometric concentration analysis
- Batch-to-batch reproducibility validation
- Microbial and endotoxin screening
Frequently Asked Questions
B7-33 6mg is used in laboratory studies involving cellular signaling, regenerative biology, protein-peptide interactions, mitochondrial metabolism, and enzymatic sensitivity assays within controlled research environments.
Currently, B7-33 does not have an assigned CAS number. However, it is fully characterized through HPLC, Mass Spectrometry, and UV analysis for research-grade validation.
No. B7-33 6mg is strictly intended for laboratory research only and is not approved for human, veterinary, medical, or cosmetic applications.
No. B7-33 6mg is strictly intended for laboratory research use only and is not approved for human or veterinary applications.
The lyophilized peptide should be stored at −20°C, protected from light and moisture. Reconstituted solutions are stable for up to 48 hours under refrigeration.
Yes. B7-33 6mg is available from EU-focused suppliers serving laboratories in Germany, France, Italy, Spain, the Netherlands, and other European countries.
B7-33 offers high molecular stability, reproducible experimental behavior, and versatility across signaling, metabolic, and regenerative research models.
Each batch is validated using HPLC, Mass Spectrometry, and UV spectrophotometry, along with identity verification and contamination screening.
European researchers value B7-33 for its consistent quality, transparent validation, EU-compliant documentation, and suitability for advanced experimental research.
Purity ≥99% is confirmed using High-Performance Liquid Chromatography (HPLC), while molecular identity is validated through Mass Spectrometry and UV spectrophotometric analysis.